BIOTON S.A. (WSE:BIO)
Poland flag Poland · Delayed Price · Currency is PLN
3.900
+0.050 (1.30%)
May 12, 2025, 5:04 PM CET
9.86%
Market Cap 334.87M
Revenue (ttm) 235.90M
Net Income (ttm) -16.43M
Shares Out 85.86M
EPS (ttm) -0.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 96,975
Average Volume 72,971
Open 3.820
Previous Close 3.850
Day's Range 3.820 - 3.930
52-Week Range 2.795 - 3.930
Beta 0.32
RSI 73.81
Earnings Date Apr 29, 2025

About BIOTON

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1989
Employees 364
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BIO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.